Home
Methadone Forum
Rate Your Program
"What's Your Story?"
The Director's View
Talk Back
Guestbook
Addiction Science
An Addict's View
Bits and Pieces
Dedications
Drug Tests
Erosion Of Rights
Federal Regulations
 Frequent Questions
Georgia Opiate Clinics
Georgia Regulations
Hepatitis HCV
   Internet  Resources
 Legal Issues
Library
Methadone Talk
Methadone and Pain
Methadone Interactions
Methadone Maintenance
Myths Of Methadone
News And Views
  Opiate Drug Treatment
     Overdosed
Pregnancy
Rights of Patients
Suboxone
Video Library
For Women Only


In 2002, President Clinton signed the Drug Addiction Treatment Act into law as part of the Children's Health Act of 2000.  The goal of DATA is to increase access to opioid addiction treatment by allowing for office-based treatment.

DATA amends the Controlled Substance Act by allowing qualified physicians to prescribe Schedule III, IV, and V medications approved for the treatment of opioid  addiction from their offices. Regulations for the prescription of Schedule II medications, such as methadone, remain unchanged.

Prescribing physicians must meet certain criteria, must be able to refer patients to counseling and ancillary services, and must agree to treat no more than 100 patients at a time (per group and per physician).

The only currently approved medications for office-based treatment of opioid addiction are buprenorphine (Subutex®) and buprenorphine/naloxone (Suboxone®). The buprenorphine/naloxone product should be used for out-patient dispensing due to the risk of injection abuse with buprenorphine alone.

Physicians must apply to the U.S. Department of Health and Human Services to receive a waiver allowing them to prescribe buprenorphine or buprenorphine/ naloxone for the management of opioid addiction.  The physician is assigned an
identification number if HHS does not block the waiver within 45 days.
Violations of DATA put a physician's Drug Enforcement Agency registration at risk.

Buprenorphine and buprenorphine/naloxone are not mentioned in DATA, but these drugs are currently the only Schedule III-IV medications approved by the FDA for treatment of drug dependence. 

If any of you are interested in acquiring more information on these medications, we have made it available for you. The link will lead you to our other website.

http://www.SuboxoneAssistedTreatment.org

Suboxone has many advantages over methadone.  ---- We at Medical Assisted Treatment of America totally support the use of Suboxone.  Yes, it has very good reviews from the people I have spoke with and the stories I have published.  I hope even if you are on methadone that you will take the time to check it out...

Compiled & Edited By:  Deborah Shrira-Publisher           Date:  May 2008

Top